In this episode of Biotalk, Josh Hamermesh, VP of Locust Walk, spoke to Fred Chereau, CEO of LogicBio, an innovative early-stage gene therapy company that recently completed a $50M financing. During the conversation, Josh and Fred discussed career paths, industry trends, gene therapy and the keys to LogicBio’s successful financing.
To hear the full conversation, listen below:
Subscribe here:
Click on the icons below to share on: